LIGAND PHARMACEUTICALS INCORPORATED Lessee, Operating Lease, Liability, to be Paid, Year Three
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) had Lessee, Operating Lease, Liability, to be Paid, Year Three of $1.12 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree · last filed 2026-02-27
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $1.12M.
- 2024-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $1.63M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $1.23M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Three $1.58M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Three |
|---|---|
| 2025-12-31 | $1.12M 10-K · filed 2026-02-27 |
| 2024-12-31 | $1.63M 10-K · filed 2025-02-28 |
| 2023-12-31 | $1.23M 10-K · filed 2024-02-29 |
| 2022-12-31 | $1.58M 10-K · filed 2023-02-28 |
| 2022-09-30 | $4.94M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $3.81M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $2.61M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $2.72M 10-K · filed 2022-02-28 |
| 2021-09-30 | $2.11M 10-Q · filed 2021-11-09 |
| 2020-12-31 | $1.77M 10-K · filed 2021-02-24 |
| 2019-12-31 | $2.26M 10-K · filed 2020-02-27 |
| 2019-09-30 | $2.14M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $2.17M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $974.00K 10-Q · filed 2019-05-09 |